| 0 |
Interleukin-36 Receptor Antagonist [EPC] |
1 |
0.0025 |
| 1 |
Histone Deacetylase Inhibitor [EPC] |
6 |
0.0015 |
| 2 |
Antiparasitic [EPC] |
7 |
0.0015 |
| 3 |
Pediculicide [EPC] |
7 |
0.0015 |
| 4 |
Interleukin-5 Antagonist [EPC] |
1 |
0.0015 |
| 5 |
CD38-directed Cytolytic Antibody [EPC] |
7 |
0.0012 |
| 6 |
Pyrethroid [EPC] |
2 |
0.0011 |
| 7 |
CD22-directed Immunoconjugate [EPC] |
1 |
0.0003 |
| 8 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
1 |
0.0003 |
| 9 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
1 |
0.0002 |
| 10 |
Antimetabolite Immunosuppressant [EPC] |
5 |
0.0002 |
| 11 |
Provitamin D2 Compound [EPC] |
6 |
0.0002 |
| 12 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
1 |
0.0002 |
| 13 |
CD52-directed Cytolytic Antibody [EPC] |
3 |
0.0002 |
| 14 |
Proteasome Inhibitor [EPC] |
17 |
0.0001 |
| 15 |
Interleukin-23 Antagonist [EPC] |
14 |
0.0001 |
| 16 |
Dopamine-2 Receptor Antagonist [EPC] |
1 |
0.0001 |
| 17 |
Interleukin-12 Antagonist [EPC] |
12 |
0.0001 |
| 18 |
Quinolone Antimicrobial [EPC] |
1 |
0.0001 |
| 19 |
CD30-directed Immunoconjugate [EPC] |
1 |
0.0001 |
| 20 |
Alkylating Drug [EPC] |
21 |
0.0001 |
| 21 |
CD20-directed Cytolytic Antibody [EPC] |
26 |
0.0001 |
| 22 |
Interleukin-6 Receptor Antagonist [EPC] |
11 |
0.0001 |
| 23 |
Topoisomerase Inhibitor [EPC] |
6 |
0.0001 |
| 24 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
10 |
0.0001 |
| 25 |
Asparagine-specific Enzyme [EPC] |
1 |
0.0001 |
| 26 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
1 |
0.0001 |
| 27 |
Nonergot Dopamine Agonist [EPC] |
1 |
0.0001 |
| 28 |
BCL-2 Inhibitor [EPC] |
4 |
0.0001 |
| 29 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
3 |
0.0001 |
| 30 |
Nucleoside Metabolic Inhibitor [EPC] |
17 |
0.0001 |
| 31 |
Sympathomimetic-like Agent [EPC] |
2 |
0.0001 |
| 32 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
6 |
0.0001 |
| 33 |
Interleukin-1 Receptor Antagonist [EPC] |
1 |
0.0001 |
| 34 |
Nucleoside Analog Antiviral [EPC] |
5 |
0.0001 |
| 35 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
3 |
0.0001 |
| 36 |
Nitrofuran Antibacterial [EPC] |
1 |
0.0001 |
| 37 |
Leukocyte Growth Factor [EPC] |
8 |
0.0001 |
| 38 |
Cholinesterase Inhibitor [EPC] |
1 |
0.0001 |
| 39 |
Selective T Cell Costimulation Modulator [EPC] |
6 |
0.0000 |
| 40 |
CTLA-4-directed Blocking Antibody [EPC] |
2 |
0.0000 |
| 41 |
Tumor Necrosis Factor Blocker [EPC] |
41 |
0.0000 |
| 42 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 43 |
PCSK9 Inhibitor [EPC] |
1 |
0.0000 |
| 44 |
Serotonin-3 Receptor Antagonist [EPC] |
5 |
0.0000 |
| 45 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
1 |
0.0000 |
| 46 |
RANK Ligand Inhibitor [EPC] |
7 |
0.0000 |
| 47 |
Folate Analog Metabolic Inhibitor [EPC] |
15 |
0.0000 |
| 48 |
Kinase Inhibitor [EPC] |
19 |
0.0000 |
| 49 |
Oxazolidinone Antibacterial [EPC] |
1 |
0.0000 |
| 50 |
Corticosteroid [EPC] |
42 |
0.0000 |
| 51 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
6 |
0.0000 |
| 52 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1 |
0.0000 |
| 53 |
Glycopeptide Antibacterial [EPC] |
2 |
0.0000 |
| 54 |
Purine Antimetabolite [EPC] |
3 |
0.0000 |
| 55 |
Xanthine Oxidase Inhibitor [EPC] |
5 |
0.0000 |
| 56 |
Thalidomide Analog [EPC] |
15 |
0.0000 |
| 57 |
Tetracycline-class Drug [EPC] |
2 |
0.0000 |
| 58 |
Potassium Channel Blocker [EPC] |
2 |
0.0000 |
| 59 |
Rifamycin Antibacterial [EPC] |
1 |
0.0000 |
| 60 |
Interleukin-17A Antagonist [EPC] |
1 |
0.0000 |
| 61 |
Calcium [EPC] |
4 |
0.0000 |
| 62 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0000 |
| 63 |
Platinum-based Drug [EPC] |
7 |
0.0000 |
| 64 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0000 |
| 65 |
Central Nervous System Stimulant [EPC] |
2 |
0.0000 |
| 66 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 67 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
2 |
0.0000 |
| 68 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
2 |
0.0000 |
| 69 |
Insulin [EPC] |
1 |
0.0000 |
| 70 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 71 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 72 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 73 |
Microtubule Inhibitor [EPC] |
3 |
0.0000 |
| 74 |
Parathyroid Hormone Analog [EPC] |
2 |
0.0000 |
| 75 |
Aromatase Inhibitor [EPC] |
2 |
0.0000 |
| 76 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 77 |
Aromatic Amino Acid [EPC] |
1 |
0.0000 |
| 78 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 79 |
Histamine-2 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 80 |
Nitroimidazole Antimicrobial [EPC] |
1 |
0.0000 |
| 81 |
Opioid Agonist [EPC] |
4 |
0.0000 |
| 82 |
Vitamin C [EPC] |
6 |
0.0000 |
| 83 |
alpha-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 84 |
Vitamin D [EPC] |
4 |
0.0000 |
| 85 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
17 |
0.0000 |
| 86 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 87 |
Vitamin B12 [EPC] |
4 |
0.0000 |
| 88 |
Platelet Aggregation Inhibitor [EPC] |
7 |
0.0000 |
| 89 |
Dihydropyridine Calcium Channel Blocker [EPC] |
4 |
0.0000 |
| 90 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 91 |
Amide Local Anesthetic [EPC] |
1 |
0.0000 |
| 92 |
Atypical Antipsychotic [EPC] |
5 |
0.0000 |
| 93 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 94 |
Partial Opioid Agonist [EPC] |
1 |
0.0000 |
| 95 |
Acetylcholine Release Inhibitor [EPC] |
1 |
0.0000 |
| 96 |
Antiarrhythmic [EPC] |
1 |
0.0000 |
| 97 |
5-alpha Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 98 |
Mood Stabilizer [EPC] |
2 |
0.0000 |
| 99 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 100 |
Anti-epileptic Agent [EPC] |
2 |
0.0000 |
| 101 |
Loop Diuretic [EPC] |
4 |
0.0000 |
| 102 |
Benzodiazepine [EPC] |
6 |
0.0000 |
| 103 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 104 |
Proton Pump Inhibitor [EPC] |
4 |
0.0000 |
| 105 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 106 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 107 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 108 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 109 |
Expectorant [EPC] |
1 |
0.0000 |
| 110 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 111 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 112 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 113 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 114 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |